Revenue segments as reported by the company.

Pharmacy revenues

Premiums

Fees and other revenues

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Pharmacy and other service costs

Medical costs and other benefit expenses

Selling, general and administrative expenses

Amortization of acquired intangible assets

Special items

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cigna

Express Scripts is a company that provides integrated pharmacy benefit management services including network-pharmacy claims processing; home delivery pharmacy services; specialty pharmacy benefit management, through its subsidiary Accredo; benefit-design consultation; drug-utilization review; formulary management; and medical and drug data analysis services to manage drug plans for health plans, self-insured employers and government agencies (both as administrator of employee benefits and public assistance programs). Express Scripts also offers pharmacy benefit management services for workers' compensation insurance programs. The program is accredited by URAC, the nation's largest accrediting body for pharmacy benefit management companies. The company processes pharmaceutical claims for members through a network of retail pharmacies. Its own automated pharmacies dispense long-term, chronic medications-like those for diabetes or heart disease-directly to members by home delivery.

Express Scripts

The Cigna Group is a global health company, which engages in the provision of global health services. It operates through the following segments: Evernorth Health Services, Cigna Healthcare, Other Operations, and Corporate. The Evernorth Health Services segment partners with health plans, employers, governmental organizations, and health care providers to solve challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. The Cigna Healthcare segment includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to clients and customers. The Other Operations segment consists of the remainder of business operations, which includes certain ongoing businesses and exited businesses. The Corporate segment refers to net interest expense, certain litigation matters, expense associated with frozen pension plans, charitable contributions, operating severance, certain overhead and enterprise-wide project costs, and eliminations for products and services sold between segments. The company was founded in 1792 and is headquartered in Bloomfield, CT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Cigna posts strong Q4 earnings, eyes growth in specialized services

Cigna delivered strong financial results in Q4 2022, with robust revenue growth and operational performance across key business segments.
While facing challenges such as margin pressures and potential disenrollment, Cigna is well-positioned to capitalize on growth opportunities in 2023.
Strategic partnerships, customer-focused strategies, and financial discipline underscore Cigna's commitment to sustainable growth and shareholder value creation.
Investments in innovation, care coordination, and market expansion signal a proactive approach to navigating industry dynamics and driving future success.

Cigna reports robust Q1 earnings, eyes growth amid challenges

Cigna's Q1 2023 showcased strong financials, growth in key segments, and increased outlook.
Challenges include economic softening impact and margin expectations for the year.
Opportunities lie in customer relationships, innovation, and market-specific strategies.
Overall, Cigna remains confident in delivering on its financial and growth targets.

Cigna reports robust Q2 results, eyes growth through innovation

Cigna's Q2 2023 performance was strong, with revenue growth, customer expansion, and technological advancements driving positive outcomes.
While facing challenges like disenrollment and risk adjustment payables, Cigna is leveraging strengths in technology and cross-selling for growth.
Opportunities lie in partnerships like VillageMD, continued innovation, and strategic bidding strategies for future growth.
Overall, Cigna remains confident in delivering on adjusted EPS outlook for 2023 and 2024, with a focus on innovation and growth.

Cigna surpasses Q3 expectations, eyes $28 EPS in 2024

Cigna's Q3 performance exceeded expectations, driven by strong revenue and EPS growth across key business segments.
Strategic focus on innovation, affordability, and client partnerships positions Cigna well for future growth and value creation.
Challenges in margin expectations and enrollment declines require proactive management and strategic decision-making.
Opportunities lie in continued growth projections, strategic investments, and enhancing healthcare affordability and accessibility.

Cigna reports robust Q4 performance, eyes growth amid strategic changes

Cigna Group's Q4 2023 Earnings Call highlighted strong financial performance, leadership changes, and strategic decisions. Analyst inquiries focused on growth drivers, market outlook, and internal healthcare spend management. The outlook for 2024 includes expectations of solid adjusted EPS, revenue growth, and operating cash flow.

Cigna surpasses Q1 expectations, eyes growth through AI and biosimilars

Cigna's Q1 performance exceeded expectations, driven by strong revenue and EPS figures.
Despite challenges like noncash losses and disruptions, Cigna's strategic strengths in AI, biosimilars, and value-based care position it well for growth.
Opportunities in AI-driven healthcare solutions, biosimilar expansions, and strategic M&A offer avenues for future growth.
Cigna's focus on precision care solutions and client outcomes showcases its commitment to innovation and efficiency.

Cigna (CI) posts robust Q2 results, eyes biosimilar growth

Cigna (CI) reports strong Q2 financial results driven by Evernorth Health Services and Express Scripts' innovative programs.
Focus on affordability, access, and behavioral health services propels growth in U.S. employer business.
Challenges include navigating healthcare cost pressures and ensuring fair pricing negotiations.
Opportunities lie in biosimilar growth, sustainable revenue outlook, and strategic Medicare Advantage business sale.

Cigna reports robust Q3 earnings, eyes growth opportunities in 2025

Cigna's Q3 earnings call highlighted strong financial performance, strategic focus on shareholder value, and challenges in specialty drugs and cost trends. The company is optimistic about opportunities in 2025 and remains committed to delivering shareholder value through strategic initiatives.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Leading health plan stocks slumped Thursday after Cigna warned about mounting pandemic costs. Monitor these chart levels for buying opportunities.

Cigna (CI) Earnings Spook Healthcare Plan Stocks

Cigna Corporation (CI) CEO David Cordani on Q2 2021 Results - Earnings Call Transcript

Cigna's (CI) better-than-expected Q2 earnings benefit from better revenues, partly offset by higher medical cost.

Cigna (CI) Q2 Earnings Beat on Revenue Growth But Shares Fall

Cigna (CI) delivered earnings and revenue surprises of 5.65% and 4.46%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Cigna (CI) Q2 Earnings and Revenues Surpass Estimates

Shares of Cigna (NYSE:CI) were unchanged after the company reported Q2 results. Quarterly Results Earnings per share were down 9.81% year over year to $5.24, which beat the estimate of $4.96.

Cigna: Q2 Earnings Insights

Cigna Corp (NYSE: CI) reports Q2 total revenues of $43.1 billion, +9.8% Y/Y, ahead of the consensus of $41.31 billion. Q2 adjusted EPS reached $5.24 compared with $5.81 a year ago, beating the consensus of $4.96.

Cigna Strongly Beats On Q2 Earnings; Raises FY21 Sales Outlook, Expects Higher Unfavorable COVID-19 Impact

Cigna Corp. reported Thursday second-quarter profit and revenue that topped forecasts, amid strength in the health insurers pharmacy business, while growth in customer relationships slowed from the previous quarter. The stock fell 2.8% in premarket trading.

Cigna beats earnings expectations and raises revenue outlook, but stock falls

(Reuters) -Health insurer Cigna Corp reported a 16.4% fall in second-quarter profit on Wednesday, hurt by higher medical costs, and said it expects a negative earnings impact from COVID-19 of about $2.50 per share for 2021.

Cigna profit falls 16.4% on higher medical costs

BLOOMFIELD, Conn., Aug. 5, 2021 /PRNewswire/ --  Total revenues in the second quarter were $43.1 billion, and adjusted revenues1 were $43.1 billion Shareholders' net income for the second quarter was $1.5 billion, or $4.25 per share Adjusted income from operations2 for the second quarter was $1.8 billion, or $5.24 per share Adjusted income from operations2,3 for 2021 is projected to be at least $20.20 per share Global health services company Cigna Corporation (NYSE: CI) today reported second quarter 2021 results, with strong diversified revenue growth across its businesses.

Cigna Reports Second Quarter 2021 Results

Cigna's (CI) Q2 results are likely to reflect an increase in revenues but a decline in its bottom line.

What's in Store for Cigna's (CI) Earnings in Q2?

BLOOMFIELD, Conn., July 30, 2021 /PRNewswire/ -- Global health service company Cigna Corporation (NYSE:CI) today announced several updates to its Board of Directors.

Cigna Corporation Announces Updates to its Board of Directors

Cigna (CI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Cigna (CI) Q2 Earnings Expected to Decline

Health insurance providers Cigna and Oscar are rolling out Oscar Virtual Primary Care for small businesses in Tennessee and Georgia on some Cigna + Oscar plans starting next year, the companies announced in a Thursday (July 22) press release. Cigna and Oscar announced their partnership early in 2020, branding the offering Cigna + Oscar.

Cigna + Oscar To Launch Virtual Primary Care Offering

Oscar Health

BLOOMFIELD, Conn. & NEW YORK--(BUSINESS WIRE)--Cigna (NYSE: CI), a global health service company, and Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), the first health insurance company built on a full stack technology platform and a relentless focus on serving its members, today announced that they are launching Oscar Virtual Primary Care on select Cigna + Oscar plans, beginning in 20221. The Virtual Primary Care offering will be available to small businesses in Tennessee and Georgia, bringing them

Cigna + Oscar Expands Convenient Access to Virtual Primary Care in Tennessee & Georgia

AbbVie

Baxter

Bristol-Myers

Cisco Systems

Chevron

D.R. Horton

Gaming and Leisure Properties

Barrick Gold

Intel

Johnson & Johnson

Lowe's

Merck

PepsiCo

Raytheon Technologies

Exxon Mobil

Kiplinger Investing publishes opportune buy-lists for investors online. Two billionaire stock-lists by Dan Burrows included 50 published 12/8/20, with 30 more out June 1, 2021. Seventeen were duplicated, leaving 63. 41 of these 63 billionaire-held stocks pay dividends. As of 7/20/21, the top-ten ranged 2.52%-6.22% by annual yield and ranged 23.13%-52.70% per broker-estimated price-target upsides.

Pre-August Billionaire Flash: 63 Stocks, 41 Dividends, 3 Buys

Assurant

Hartford Financial Services Group

Horace Mann Educators

MetLife

Prudential Financial

Better pricing, product redesigns, technological advancement along with optimistic growth outlook are expected to aid multiline insurers like MET, AIG, CI, HIG, PRU, AIZ and HMN as the impact of the pandemic recedes.

7 Multiline Insurers to Watch Out For as Economic Recovery Gains Traction

BLOOMFIELD, Conn., July 15, 2021 /PRNewswire/ -- Global health service company Cigna Corporation (NYSE:CI) will release its second quarter 2021 financial results on Thursday, August 5, 2021, and will host a conference call the same day.

Cigna Corporation's Second Quarter 2021 Earnings Release Details

Cigna is down 12% from its YTD high. The fundamentals are solid and growth targets look achievable.

Cigna Looks Compelling

ATLANTA, July 13, 2021 /PRNewswire/ -- Cigna (NYSE:CI) has named Bonnie Evelyn as market president for its health care and related benefits plans in Georgia/Alabama. She replaces former market president Bryan Holgerson, who was promoted to Chief Underwriting Officer for Cigna U.S. Commercial.

Bonnie Evelyn Named Cigna Market President for Georgia/Alabama

Amalgamated Financial Corp

America's Car-Mart

Federated Hermes

Turtle Beach

Hologic

Labcorp Holdings Inc

Lumber Liquidators

Zumiez

To call a beautiful woman a “Perfect 10” these days would be considered chauvinistic and outdated.

The Perfect 10 Portfolio Returned 69% Last Year

We think that Cigna (NYSE: CI) currently is a better pick compared to UnitedHealth Group. CI stock trades at about 0.5x trailing revenues, compared to around 1.5x for UnitedHealth.

Here's Why Cigna Is A Better Buy Compared To UnitedHealth Group Stock

Cigna (CI) is currently riding on solid top-line growth, expanding global presence and prudent capital deployment.

Here's Why You Should Hold on to Cigna (CI) Stock for Now

GlaxoSmithKline

Vertex Pharmaceuticals

The three stocks listed below could be of interest to growth-oriented investors, as they represent equities in businesses whose price-earnings ratios are below 20 while their trailing 12-month earnings per share increased significantly over the past year.

A Trio of Stock Picks for Growth-Oriented Investors

WASHINGTON, July 1, 2021 /PRNewswire/ -- Cigna Corporation CEO David Cordani hosted an exclusive fireside conversation with President George W. Bush on Wednesday to honor American veterans and support athletes on the Achilles International Freedom Team, which is composed of wounded members of the U.S. military.

President George W. Bush Joined Cigna Corporation CEO David Cordani to Honor American Veterans and Support the Achilles International Freedom Team

Cigna is an underappreciated e-healthcare provider. Cigna's valuation hasn't recovered after the correction in 2018 and its merger with Express Scripts.

News for Cigna Stock (CI)